Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN B KING

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1174023352
CMS profile
10822739
Location
TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$15,743.22

129 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JONATHAN B KING

NPI 1174023352 · CMS profile ID 10822739

Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family

TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174023352?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174023352?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174023352?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 129 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1174023352?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

129 matching records · $15,743.22 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 129 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 129.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $13.8207/16/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1223256162 CMS
Bayer Healthcare Pharmaceuticals Inc. $124.1407/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225607009 CMS
Janssen Biotech, Inc. $24.9506/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175168580 CMS
Novartis Pharmaceuticals Corporation $83.3306/12/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200251694 CMS
Geron Corporation $23.5806/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238899735 CMS
Dendreon Pharmaceuticals LLC $20.6706/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245015777 CMS
ABBVIE INC. $2,100.0006/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1204555530 CMS
Astellas Pharma US Inc $16.5006/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238804414 CMS
SOBI, INC $19.6705/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240235414 CMS
ABBVIE INC. $18.0405/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555527 CMS
AstraZeneca Pharmaceuticals LP $23.4005/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206562681 CMS
PFIZER INC. $29.2205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230472079 CMS
Daiichi Sankyo Inc. $21.1805/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197062915 CMS
ABBVIE INC. $24.7205/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555518 CMS
ABBVIE INC. $24.9005/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555523 CMS
ABBVIE INC. $5.2505/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555511 CMS
ABBVIE INC. $13.5305/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555515 CMS
ABBVIE INC. $220.8605/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555494 CMS
ABBVIE INC. $125.0005/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555499 CMS
ABBVIE INC. $326.2005/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555502 CMS
ABBVIE INC. $74.8105/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555507 CMS
Novartis Pharmaceuticals Corporation $83.3305/15/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200251690 CMS
Genentech USA, Inc. $20.8205/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211641517 CMS
Genentech USA, Inc. $17.2205/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211641514 CMS
Regeneron Healthcare Solutions, Inc. $17.2105/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213153368 CMS
Janssen Biotech, Inc. $23.4705/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175169860 CMS
ABBVIE INC. $2,100.0005/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1204555490 CMS
GENZYME CORPORATION $18.5004/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233662825 CMS
Stemline Therapeutics Inc. $22.0704/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244122256 CMS
Exelixis Inc. $18.5604/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218817026 CMS
Novartis Pharmaceuticals Corporation $83.3304/24/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200251692 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.0104/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225607007 CMS
Aveo Pharmaceuticals, Inc. $20.6504/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199907354 CMS
Myriad Genetic Laboratories, Inc. $43.6804/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245415972 CMS
ABBVIE INC. $6.9704/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555487 CMS
ARRAY BIOPHARMA INC $27.1904/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229150040 CMS
ABBVIE INC. $261.4904/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555455 CMS
ABBVIE INC. $125.0004/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555459 CMS
ABBVIE INC. $1,279.8504/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555463 CMS
ABBVIE INC. $18.1304/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555469 CMS
ABBVIE INC. $41.8204/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204555474 CMS
ABBVIE INC. $51.9004/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555479 CMS
ABBVIE INC. $962.9604/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1204555483 CMS
Karyopharm Therapeutics Inc. $14.4904/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246654899 CMS
PFIZER INC. $17.8304/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229236644 CMS
Apellis Pharmaceuticals, Inc. $18.9304/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253209765 CMS
Aveo Pharmaceuticals, Inc. $6.7704/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199907358 CMS
E.R. Squibb & Sons, L.L.C. $18.8204/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184723586 CMS
AstraZeneca Pharmaceuticals LP $31.2204/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206153864 CMS
Janssen Biotech, Inc. $33.9204/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175168729 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $6,141.32 32
PY2022 $46,162.52 90
PY2023 $17,335.67 81
PY2024 $11,836.09 113
PY2025 $15,743.22 129

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Recipient $2,489.12 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Regeneron Pharmaceuticals, Inc. $38.84 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398716
Recipient Regeneron Pharmaceuticals, Inc. $55.00 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398718
Recipient Regeneron Pharmaceuticals, Inc. $162.14 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398720
Recipient Regeneron Pharmaceuticals, Inc. $316.71 03/22/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398712
Recipient Regeneron Pharmaceuticals, Inc. $603.22 03/22/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398714
Recipient Regeneron Pharmaceuticals, Inc. $21.86 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398700
Recipient Regeneron Pharmaceuticals, Inc. $31.15 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398702
Recipient Regeneron Pharmaceuticals, Inc. $43.47 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398704
Recipient Regeneron Pharmaceuticals, Inc. $62.30 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398706
Recipient Regeneron Pharmaceuticals, Inc. $77.56 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398708
Recipient Regeneron Pharmaceuticals, Inc. $130.74 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398710
Recipient Regeneron Pharmaceuticals, Inc. $134.92 03/20/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398698
Recipient Regeneron Pharmaceuticals, Inc. $811.21 02/26/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398696